Activity Of Imatinib (Gleevec®) In Metastatic Renal Cell Carcinoma
Tue, 07 Mar 2006 06:00 PM EST
... Until recently, standard therapy for metastatic renal cell carcinoma (RCC) has been immunotherapy with either interleukin 2 or interferon. New targeted therapies that target specific molecular pathways important in malignant transformation and progression have been developed and are currently the subject of intense clinical investigation in a variety of malignancies... click link for more info. ...
Related Topics
- Skin Cancer
- Renal Cell Cancer
- Renal cell carcinoma
- Physical Activity
- Kidney Cancer
- Imatinib
- Metastatic Cancer
- Liver Cancer
- Small Cell Lung Cancer
- Merkel Cell Carcinoma
- Renal Cell (Kidney) Cancer
- Kidney (Renal Cell) Cancer
- Islet Cell Carcinoma
- Islet Cell Carcinoma (Pancreatic)
- Skin Carcinoma, Merkel Cell
- Squamous Cell Carcinoma, see Skin Cancer
- Islet Cell Carcinoma (Endocrine Pancreas)
- Basal Cell Carcinoma, see Skin Cancer
- Brain Cancer
- Sickle Cell Anemia

Not Signed In -


